Combination cell therapy with mesenchymal stem cells and neural stem cells for brain stroke in rats SM Hosseini, M Farahmandnia, Z Razi, S Delavari, B Shakibajahromi, ... International Journal of Stem Cells 8 (1), 99-105, 2015 | 45 | 2015 |
A systems biology roadmap to decode mTOR control system in cancer M Dorvash, M Farahmandnia, I Tavassoly Interdisciplinary Sciences: Computational Life Sciences 12 (1), 1-11, 2020 | 35 | 2020 |
Aging and stem cell therapy: AMPK as an applicable pharmacological target for rejuvenation of aged stem cells and achieving higher efficacy in stem cell therapy M Khorraminejad-Shirazi, M Farahmandnia, B Kardeh, A Estedlal, ... Hematology/oncology and stem cell therapy 11 (4), 189-194, 2018 | 35 | 2018 |
The preventive effects of neural stem cells and mesenchymal stem cells intra-ventricular injection on brain stroke in rats SM Hosseini, N Samimi, M Farahmandnia, B Shakibajahromi, ... North American Journal of Medical Sciences 7 (9), 390, 2015 | 20 | 2015 |
Dynamic modeling of signal transduction by mTOR complexes in cancer M Dorvash, M Farahmandnia, P Mosaddeghi, M Farahmandnejad, ... Journal of Theoretical Biology 483, 109992, 2019 | 18 | 2019 |
12 hours after cerebral ischemia is the optimal time for bone marrow mesenchymal stem cell transplantation SM Hosseini, M Farahmandnia, Z Razi, S Delavarifar, B Shakibajahromi Neural Regeneration Research 10 (6), 904-908, 2015 | 13 | 2015 |
A novel cell therapy method for recovering after brain stroke in rats SM Hosseini, M Farahmandnia, S Kazemi, B Shakibajahromi, ... International Journal of Stem Cells 8 (2), 191-199, 2015 | 6 | 2015 |
Major causes of death: spotlight on mTOR pathway M Farahmandnia, M Khorraminejad-Shirazi, M Dorvash MOJ Cell Science & Report 4 (1), 27-28, 2017 | | 2017 |
脑缺血后 12h 尾静脉注射骨髓间充质干细胞为保护脑缺血的最佳时机 SM Hosseini, M Farahmandnia, Z Razi, S Delavarifar, B Shakibajahromi 中国神经再生研究 (英文版) 10 (6), 904, 2015 | | 2015 |